PT Diagnos Laboratorium Utama Tbk (IDX:DGNS)
Indonesia flag Indonesia · Delayed Price · Currency is IDR
244.00
0.00 (0.00%)
Sep 2, 2026, 1:56 PM WIB

IDX:DGNS Balance Sheet

Millions IDR. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
16,7438,4754,20910,24528,01144,720
Short-Term Investments
1,4581,458959.591,6962,5436,507
Cash & Short-Term Investments
18,2019,9335,16911,94130,55351,227
Cash Growth
308.77%92.17%-56.71%-60.92%-40.36%209.75%
Accounts Receivable
46,66646,27641,81038,28042,42241,730
Other Receivables
8,25110,4277,0796,9727,03332,209
Receivables
54,91756,70348,88945,25249,45573,939
Inventory
5,4846,0795,0435,1426,5677,760
Prepaid Expenses
104.81357.75275.79194.89266.08784.92
Other Current Assets
35,87118,12519,23125,27531,53220,153
Total Current Assets
114,57891,19878,60887,805118,373153,864
Property, Plant & Equipment
205,621209,420202,426164,248109,21987,107
Long-Term Investments
12,95112,95112,95112,9518,445-
Other Intangible Assets
2,7881,6701,353720.43681.12-
Long-Term Deferred Tax Assets
697.72697.72815.571,0311,0201,012
Other Long-Term Assets
2,7362,7363,8694,7192,198-
Total Assets
339,370318,672300,022271,475239,936241,983

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
7,3708,9219,5516,0903,0784,524
Accrued Expenses
4,7626,4464,1163,1781,5563,125
Current Portion of Long-Term Debt
1,9532,612152.08-1,701-
Current Portion of Leases
2,4084,3945,0123,7101,8112,390
Current Income Taxes Payable
486.09153.71255.12268.87674.8316,013
Current Unearned Revenue
6,9304,7781,748651.53893.77-
Other Current Liabilities
389310.34772.59545.72777.24576.26
Total Current Liabilities
24,29827,61521,60614,44410,49226,628
Long-Term Debt
49,26749,50844,81730,0009,358-
Long-Term Leases
19,43220,63220,40121,004409.042,888
Long-Term Unearned Revenue
6,2906,8007,820---
Pension & Post-Retirement Benefits
1,7281,5481,2922,1561,6863,103
Other Long-Term Liabilities
8,1368,5787,9548,2807,5637,563
Total Liabilities
109,151114,682103,89075,88529,50840,182

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
34,37531,25031,25031,25031,25031,250
Additional Paid-In Capital
62,83336,70736,70736,70736,70736,707
Retained Earnings
132,180135,202132,265131,518145,173132,509
Comprehensive Income & Other
831.26831.26-4,090-3,884-2,7021,335
Shareholders' Equity
230,219203,990196,132195,590210,428201,800
Total Liabilities & Equity
339,370318,672300,022271,475239,936241,983

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
73,05977,14670,38254,71413,2795,277
Net Cash (Debt)
-54,859-67,214-65,213-42,77317,27445,950
Net Cash Growth
-----62.41%229.33%
Net Cash Per Share
-41.80-53.77-52.17-34.2213.8237.04
Filing Date Shares Outstanding
1,3751,2501,2501,2501,2501,250
Total Common Shares Outstanding
1,3751,2501,2501,2501,2501,250
Working Capital
90,27963,58257,00273,361107,881127,236
Book Value Per Share
167.43163.19156.91156.47168.34161.44
Tangible Book Value
227,431202,320194,779194,870209,747201,800
Tangible Book Value Per Share
165.40161.86155.82155.90167.80161.44
Land
60,80260,80254,64343,65543,65543,655
Buildings
82,77382,773----
Machinery
49,70348,58646,44744,28539,54831,771
Construction In Progress
13,83813,62788,00153,06118,411311.4
Leasehold Improvements
27,86127,72127,85726,02623,67214,201